Global Longlife Hospital & Research (BOM:543520) EBIT : ₹-15.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Global Longlife Hospital & Research EBIT?

Global Longlife Hospital & Research's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ₹-36.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-15.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Global Longlife Hospital & Research's annualized ROC % for the quarter that ended in Mar. 2024 was -9.70%. Global Longlife Hospital & Research's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -22.15%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Global Longlife Hospital & Research's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -3.26%.

Global Longlife Hospital & Research EBIT Historical Data

The historical data trend for Global Longlife Hospital & Research's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Longlife Hospital & Research EBIT Chart

Global Longlife Hospital & Research Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

Get a 7-Day Free Trial

13.12

40.39

72.18

31.08

-14.98

Global Longlife Hospital & Research Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT	Get a 7-Day Free Trial				9.60	12.68	18.40	21.15	-36.12

Competitive Comparison of Global Longlife Hospital & Research's EBIT

For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Longlife Hospital & Research's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Global Longlife Hospital & Research's EV-to-EBIT falls into.

Global Longlife Hospital & Research EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-15.0 Mil.

Global Longlife Hospital & Research (BOM:543520) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Global Longlife Hospital & Research's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-73.092 * ( 1 - 19.07% )	/	( (744.211	+	475.812)	/ 2 )
=	-59.1533556	/	610.0115
=	-9.70 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	784.447	-	9.052	-	( 31.184	-	max(0, 115.704	-	367.72	+	31.184	))
=	744.211

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	417.304	-	25.588	-	( 3.854	-	max(0, 123.323	-	39.227	+	3.854	))
=	475.812

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Global Longlife Hospital & Research's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-72.246	/	( ( (175.946 + max(303.733, 0))	+	(172.57 + max(-5.575, 0)) )	/	2 )
=	-72.246	/	( ( 479.679	+	172.57 )	/	2 )
=	-72.246	/	326.1245
=	-22.15 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(125.963	+	12.942	+	181.372)	-	(9.052	+	0	+	7.492)
=	303.733

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(19.46	+	4.372	+	0.645)	-	(25.588	+	0	+	4.464)
=	-5.575

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Global Longlife Hospital & Research's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-14.976	/	459.514
	=	-3.26 %

Global Longlife Hospital & Research EBIT Related Terms

Thank you for viewing the detailed overview of Global Longlife Hospital & Research's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Longlife Hospital & Research (BOM:543520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Longlife Hospital & Research Ltd (BOM:543520) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pakwan Cross Road, Near Sindhubhavan Road, Near Water Tank, Opposite Auda Garden, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.globalhospital.co.in

Global Longlife Hospital & Research Ltd provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services.

Global Longlife Hospital & Research (BOM:543520) Headlines

No Headlines